Ebola and Infection Prevention - Rely+On® Virkon®

Where Rely+On® Virkon® Fits in High-Consequence Biosecurity

Ebola is not a routine UK domestic infection. The UK Health Security Agency (UKHSA) continues to assess the overall risk to the UK general public as low, and confirmed imported cases remain exceptionally rare. Nevertheless, Ebola is a Category 4 High Consequence Infectious Disease (HCID) carrying significant clinical and biosecurity consequences. The fundamental operational disciplines required to prevent transmission – early clinical recognition, prompt isolation, strict barrier protection, safe containment of bodily fluids, and disciplined environmental decontamination – represent vital knowledge for medical practitioners, laboratory professionals, care staff, port authorities, and animal care specialists alike.

Within clinical and laboratory environments, Rely+On® Virkon® serves as an established broad-spectrum disinfectant for non-porous hard surfaces and equipment. However, achieving genuine infection control requires absolute clarity on where chemical disinfection begins and where it ends: it is an essential supporting layer for environmental hygiene, but never a standalone cure, never a replacement for personal protective equipment (PPE), and never a substitute for official UK Government viral haemorrhagic fever management protocols.

Core Principle: Disinfectants cannot compensate for delayed patient isolation, improper personal protective equipment (PPE), or uncontrolled handling of infectious body fluids. Rely+On® Virkon® provides proven chemical inactivation on suitable hard surfaces and equipment but must operate strictly within official NHS and UKHSA infection prevention and control frameworks.

Epidemiology: Preparedness

According to the UK Government’s publication on Ebola origins, history, and transmission (GOV.UK), Ebola disease (EBOD) is caused by orthoebolaviruses belonging to the Filoviridae family. First identified in 1976 in near-simultaneous outbreaks in the Democratic Republic of the Congo (then Zaire) and South Sudan, these enveloped RNA viruses are among the deadliest pathogens known to human medicine, with historical case fatality rates ranging from 25% up to 90% depending on viral species, patient age, and clinical interventions.

Four distinct orthoebolavirus species cause disease in humans: Ebola virus (Zaire, EBOV), Sudan virus (SUDV), Bundibugyo virus (BDBV), and Taï Forest virus (TAFV). The UK overview highlights that between 2014 and 2016, West Africa experienced an unprecedented epidemic primarily driven by EBOV across Guinea, Liberia, and Sierra Leone, resulting in over 28,000 cases and widespread urban transmission, with imported cases identified in several nations including the United Kingdom, Spain, Italy, and the United States.

The global situation continues to demand vigilance. On 17 May 2026, the World Health Organization (WHO) declared an outbreak of Ebola disease caused by the Bundibugyo virus affecting the Democratic Republic of the Congo and Uganda to be a Public Health Emergency of International Concern (PHEIC). By September 2026, UKHSA reported sustained transmission concentrated across eastern DRC health zones (with over 6,700 confirmed cases and 3,200 confirmed deaths), while Uganda successfully contained its imported cluster and declared an end to transmission on 27 August 2026. While the UK risk remains low and historical imported UK cases total just four (one laboratory incident in 1976 and three healthcare worker repatriations in 2014–2015, with zero fatalities), maintaining robust, rehearsed decontamination protocols is essential across the healthcare and border security infrastructure.

Transmission Dynamics and Environmental Vulnerability

Understanding how the virus spreads is fundamental to designing effective infection prevention protocols. Orthoebolaviruses are zoonotic pathogens whose natural reservoir is believed to be fruit bats of the Pteropodidae family. Spillover into human populations occurs through direct contact with the blood, secretions, organs, or bodily fluids of infected wild animals – including chimpanzees, gorillas, and forest antelopes – either through hunting, butchering, or handling carcasses.

Once introduced into human populations, transmission occurs strictly through direct or indirect physical contact:

Person-to-Person Contact: Direct contact through broken skin, cuts, or mucous membranes (eyes, nose, mouth) with the blood, vomit, faeces, urine, saliva, or other bodily secretions of an infected person.

Fomite Transmission: Touching contaminated medical devices, instruments, needles, soiled bed linen, clothing, mattresses, or hard surfaces that have been soiled with infectious secretions.

Burial Practices: Traditional funeral rituals involving intimate handling, washing, or touching of the deceased represent a major driver of transmission due to high viral loads in post-mortem tissues.

Persistent Reservoirs: Orthoebolaviruses persist for extended periods in immune-privileged anatomical sites, including the testes, eyes, placenta, and central nervous system. Sexual transmission via semen has been documented more than a year following clinical recovery.

Crucially, GOV.UK notes that there is no circumstantial or epidemiological evidence of airborne transmission of orthoebolaviruses through coughing or sneezing, nor does the virus penetrate healthy, intact skin. However, in late-stage disease, patients experience profuse diarrhoea, recurrent vomiting, and internal or external haemorrhage. During this phase, every millilitre of blood and gastrointestinal fluid contains millions of viral particles. Decontaminating these biohazards safely without generating infectious splashes or aerosols is the primary physical challenge in acute biosecurity.

UK Government Clinical Guidelines:

Containment and Disinfection

The UK Advisory Committee on Dangerous Pathogens (ACDP) and the UK Health Security Agency set out precise requirements for managing suspected and confirmed Viral Haemorrhagic Fever cases in acute hospitals. When a returning traveller or contact presents with unexplained fever and potential VHF exposure, NHS facilities must immediately enact enhanced infection prevention and control (IPC) protocols:

Immediate Side-Room Isolation: Immediate transfer of the patient to a dedicated negative-pressure side room with en-suite sanitary facilities or a dedicated commode, restricting access strictly to trained clinical personnel.

Strict Contact Precautions: Staff entering the room must wear full High Consequence Infectious Disease (HCID) PPE, including liquid-impermeable coveralls or gowns, double medical gloves certified for chemical and biohazard resistance, fluid-resistant FFP3 respiratory protection, and full facial visors.

Specialist Escalation: Urgent testing for malaria and initial differential diagnostics must proceed alongside discussion with the national Imported Fever Service (IFS). Confirmed cases require coordinated transfer to a specialist High-Level Isolation Unit (HLIU) such as the Royal Free Hospital in London or Newcastle Royal Victoria Infirmary.

Category A Waste Stream: All clinical waste, single-use instruments, bed linen, disposable overshoes, and PPE must be double-bagged and processed strictly through Category A infectious waste streams.

From an environmental hygiene standpoint, the ACDP guidance highlights a reassuring microbiological reality: filoviruses are enveloped RNA viruses. Enveloped viruses possess an outer lipid membrane that makes them structurally fragile and readily susceptible to broad-spectrum chemical disinfectants, including chlorine compounds, peroxygens, alcohols, and thermal inactivation (heating at 60°C for 60 minutes or 75°C for 30 minutes). Standard decontamination regimens effective against blood-borne pathogens such as Hepatitis B and HIV are biologically effective against Ebola.

Where Rely+On® Virkon® Fits

Manufactured by LANXESS, Rely+On® Virkon® is the human-health and institutional formulation of the Virkon disinfectant family, distinct from agricultural Virkon® S, which is tailored for livestock housing and veterinary premises. The manufacturer positions Rely+On® Virkon® for medical, laboratory and public-health applications, with broad-spectrum activity against viruses, bacteria and fungi on appropriate hard surfaces and equipment.

The important practical point is not to overstate the chemistry. Rely+On® Virkon® is an oxidising disinfectant, but users should rely on the current UK product label, instructions for use and safety data sheet for the exact formulation, approved organisms, dilution, contact time, material compatibility and disposal requirements. The product can support a VHF cleaning programme; it does not create a separate Ebola protocol.

LANXESS reports broad-spectrum activity across a wide range of organisms and a 1% use solution for hard-surface disinfection with a 10-minute wet contact time in the product information reviewed for this article. Those claims are product-performance information, not permission to use Rely+On® Virkon® in every VHF situation or to replace the chlorine-based concentrations and procedures specified in current UK Government guidance.

Rely+On® Virkon® vs. Sodium Hypochlorite in UK Practice

Parameter	Rely+On® Virkon®	Sodium Hypochlorite (Bleach)
Active Chemistry	Potassium peroxymonosulfate oxidising system with surfactant	Sodium hypochlorite (NaOCl) yielding free available chlorine
Standard Surface Dilution	1% (1:100) where the current product information specifies this use	1,000 ppm available chlorine (approx. 1:50 dilution of 5% bleach)
Blood & Fluid Spillage Protocol	Use powder or solution only where the current UK instructions and local VHF procedure approve it	10,000 ppm available chlorine (1:5 dilution of 5% bleach) for 2 min contact
Working Solution Stability	Check the current UK instructions; daily replenishment is prudent in high-risk areas	Must be prepared freshly each day; degrades rapidly in light/heat
Material Compatibility & Safety	Check compatibility before use; follow PPE and residue requirements	Can corrode metals, bleach fabrics and release hazardous fumes

 

Biohazard Response Scenarios

To appreciate the practical application of infection prevention guidelines, consider how protocols operate during real-life acute events in clinical and laboratory practice:

Scenario A:

The Acute Clinical Assessment Area Spillage

An adult traveller presenting to an acute hospital with acute fever and bleeding following arrival from a declared outbreak region vomits heavily onto an impervious vinyl examination floor. The patient is categorised as 'at-risk of VHF'. How should clinical teams respond?

1. Immediate Containment: Access to the room is immediately sealed. No unprotected staff or cleaning personnel may enter. The lead clinician alerts the hospital IPC lead and the Imported Fever Service.

2. Responder Protection: Responders do full HCID PPE: water-impermeable gown, fluid-repellent FFP3 respirator, eye visor, double chemical-resistant nitrile gloves, and fluid-resistant boot covers.

3. Liquid Binding: Staff do not scrub or vigorously mop the vomit, which could generate aerosols. Approved absorbent material or spill-control granules are gently applied according to the local VHF procedure. If Rely+On® Virkon® powder is specifically approved for the task, it must be used exactly as directed; where the NHS procedure mandates chlorine or NaDCC, that procedure takes precedence.

4. Surface Disinfection: The bound material is swept into a dedicated Category A biohazard bag using a disposable scraper. The responsible infection-control team then applies the approved disinfectant at the specified concentration and contact time. For Rely+On® Virkon®, use the current UK instructions only where they approve the intended application; for hypochlorite, follow the GOV.UK VHF procedure.

5. Waste Disposal & Clearance: Wipes, scraper, and outer gloves are discarded into Category A containers for high-temperature incineration. The floor is rinsed with warm water and detergent once contact time elapses.

Scenario B:

Diagnostic Laboratory Surface and Equipment Decontamination

A Category 3 containment laboratory processes blood films for malaria exclusion from a suspect VHF patient. Diagnostic equipment, centrifuge buckets, and stainless steel workbenches are subject to regular decontamination:

Material Preservation: Repeated exposure to 10,000 ppm chlorine bleach rapidly pits stainless steel, corrodes centrifuge components, and degrades electronic housing seals. Rely+On® Virkon® at a 1% dilution offers a verified virucidal profile with significantly superior material compatibility.

Bench Sanitation: Laboratory workbenches are wiped down with freshly prepared 1% Rely+On® Virkon® at the end of each analytical cycle, leaving surfaces wet for 10 minutes before wiping dry, safeguarding laboratory technicians against contact transmission.

High-Consequence Infection Prevention Checklist

For medical facilities, diagnostic laboratories, travel clinics, and emergency services establishing standard operating procedures, this practical checklist ensures robust preparedness:

Accessible Protocols: Display the national VHF clinical algorithm and maintain 24/7 contact details for local infectious disease consultants, the Imported Fever Service (IFS), and NHS England EPRR.

Spill Kits & PPE Staging: Maintain dedicated HCID assessment packs and VHF biohazard spill kits in acute assessment zones. Ensure clinical staff receive scheduled training in donning and doffing sequence drills.

Strict Rely+On® Virkon® Dilution: Prepare Rely+On® Virkon® only at the concentration and by the method specified in the current UK instructions for use. The manufacturer information reviewed for this article describes a 1% hard-surface solution and a 10-minute wet contact time; do not transfer those details to an unapproved VHF task without confirmation from the label and infection-control lead.

Respect Contact Times: Never wipe away disinfectant prematurely. Keep the surface visibly wet for the full contact time specified for the approved product and task; if UK VHF guidance or the local policy specifies another disinfectant, concentration or time, follow that procedure.

Solidify Liquid Spills: Always apply dry powder or high-absorbency gelling agents to bulk vomit, faeces, or blood before liquid washing to prevent aerosol dispersion and uncontrolled liquid spread.

Category A Waste Compliance: All materials, cloths, gloves, and protective gear contacting suspected VHF bodily fluids must be double-bagged in UN-approved Category A containers for high-temperature incineration.

Emergency Exposure Drills: In the event of needle-stick injury or splash to skin, wash immediately with soap and water (encourage needle-stick bleeding gently); for mucous membrane contact, irrigate copiously with eyewash and report immediately.

Balancing Chemical Efficacy and Process Discipline

Controlling high-consequence viral pathogens such as Ebola is fundamentally an exercise in disciplined, multi-layered biosecurity. Disinfectants are the chemical workhorses that neutralise viruses on contaminated surfaces, preventing indirect fomite transmission. Rely+On® Virkon® offers exceptional broad-spectrum efficacy, proven enveloped virus destruction, superior material compatibility over corrosive bleach, and practical convenience in both powder and tablet formats.

Chemical potency is powerless without clinical vigilance. Fast identification, immediate isolation, expert veterinary and human clinical oversight, impervious barrier protection, and compliance with national ACDP guidelines form the true shield against disease transmission. When robust protocols and validated disinfectants work hand in hand, public health and clinical personnel can manage high-consequence threats with calm, evidence-based authority.

Sources and Official Guidance

GOV.UK: Ebola: overview, history, origins and transmission – https://www.gov.uk/government/publications/ebola-overview-history-origins-and-transmission/ebola-overview-history-origins-and-transmission

UK Health Security Agency: Risk assessment and immediate management of viral haemorrhagic fevers (ACDP algorithm) – https://www.gov.uk/government/publications/viral-haemorrhagic-fever-acdp-algorithm-and-guidance-on-management-of-patients/risk-assessment-and-immediate-management-of-viral-haemorrhagic-fevers-contact-high-consequence-infectious-diseases-in-acute-hospitals

UK Health Security Agency: Ebola and Marburg haemorrhagic fevers: outbreaks and case locations – https://www.gov.uk/guidance/ebola-and-marburg-haemorrhagic-fevers-outbreaks-and-case-locations

World Health Organization: Bundibugyo Ebola Disease in DRC and Uganda determined a PHEIC – https://www.who.int/news/item/17-05-2026-epidemic-of-ebola-disease-in-the-democratic-republic-of-the-congo-and-uganda-determined-a-public-health-emergency-of-international-concern

LANXESS: Rely+On® Virkon® Disinfectant Technical Profile & Instructions for Use – https://lanxess.com/en-us/products/brands/rely-on-disinfection

LANXESS: Rely+On® Virkon® Laboratory & Healthcare Surface Disinfectant Brochure – https://lanxess.com/-/media/project/lanxess/corporate-internet/products-and-solutions/brands/rely-on/brochurerelyon-virkon082024-2.pdf

UK Health & Safety Executive: Management of Hazard Group 4 viral haemorrhagic fevers – https://www.gov.uk/government/publications/viral-haemorrhagic-fever-acdp-algorithm-and-guidance-on-management-of-patients